ERECTILE DYSFUNCTION IN UZBEKISTAN: EPIDEMIOLOGY, RISK FACTORS, AND MODERN TREATMENT APPROACHES
Abstract
Erectile dysfunction is one of the most common, multifactorial, and clinically significant disorders of men's health. It not only reduces the quality of sexual life but also often manifests as an early clinical sign of cardiovascular, endocrine, metabolic, and psychogenic problems. The purpose of this literature review is to systematize the available scientific evidence on erectile dysfunction in Uzbekistan, highlight epidemiological gaps, identify key risk factors, and analyze modern treatment approaches based on scientific evidence. The analysis shows that while local literature contains some clinical observations and methodological works on ED, standardized nationwide epidemiological studies are still insufficient. International guidelines recommend a stepwise approach to diagnosing and treating ED, including lifestyle modification, PDE5 inhibitors, vacuum devices, intracavernosal therapy, and penile prostheses. Therefore, in the context of Uzbekistan, early detection of ED, active management of risk factors, and the implementation of a multidisciplinary clinical model remain priority directions.
References
[1] Abbosov Sh.A., Makhmudov A.T., Mukhtarov Sh.T., Aliyev S.U., Tulaboev A.K. Epidemiology of erectile dysfunction in Uzbekistan: methodological justification. Bulletin of the Association of Physicians of Uzbekistan. 2025;4(121):106–111.
[2] Makhmudov A.T., Abbosov Sh.A., Tulaboev A.K., Aliyev S.U., Shavakhabov Sh.Sh., Akilov F.A. Validation of the International Index of Erectile Function in Uzbekistan: study of linguistic, cultural and ethical features for accurate application. Journal of Clinical and Preventive Medicine. 2025.
[3] Abbosov Sh.A., Makhmudov A.T., Tulaboev A.K., Aliev S.U., Shavakhabov Sh.Sh., Akilov F.A. Cross-cultural adaptation and ethical considerations of the International Index of Erectile Function in Uzbekistan: a methodological review. Journal of Clinical and Preventive Medicine. 2025.
[4] Abbosov Sh.A. Erectile dysfunction: a view on diagnosis, treatment and new interventions. 2025.
[5] Abbosov Sh.A., Makhmudov A.T., Tulaboev A.K., Aliyev S.U., Shavakhabov Sh.Sh., Akilov F.A. Systematic evaluation of penile implants for erectile dysfunction: a comprehensive analysis of effectiveness, safety, and patient satisfaction. Bulletin of TMA. 2025.
[6] Rashidov Z.R., Tirkashev Sh.T. Effectiveness of L-arginine in long-term use in the treatment of erectile dysfunction. Problems of Biology and Medicine. 2023;5.1(149).
[7] Ashurmetov A.M. Prevalence of Erectile Dysfunction among men of the Uzbek Population who were on the Inpatient Examination and Treatment. Global Journal of Urology. 2020;2:8–10.
[8] Clinical aspects of erectile dysfunction in patients with type 2 diabetes mellitus. Doctors Herald / Doctor axborotnomasi. 2022.
[9] Frequency of circulatory disorders in the iliac arteries among urological patients. TMA article. Reference opened in 2024.
[10] Epidemiology of male urological pathology: Uzbekistan through the lens of world statistics. SamMU. 2024.
[11] Salonia A. et al. 2025 Update on Male Hypogonadism, Erectile Dysfunction, Premature Ejaculation… European Urology / PubMed. 2025.
[12] European Association of Urology. Management of Erectile Dysfunction. EAU Sexual and Reproductive Health Guidelines. Updated online guide.
[13] Leslie S.W. et al. Erectile Dysfunction. StatPearls. 2024.
[14] Kitaw T.A. et al. The global burden of erectile dysfunction and its associated risk in diabetic patients: systematic review/meta-analysis. 2024.
[15] Risk factors for erectile dysfunction in diabetes mellitus. PubMed-indexed review/meta-analysis. 2024.
[16] Chen Z. et al. Effect of different physical activities on erectile dysfunction: systematic review/meta-analysis. 2024.
[17] Zhu Z. et al. The safety and efficacy of phosphodiesterase type 5 inhibitors in diabetic erectile dysfunction: meta-analysis. 2025.
[18] Zhang F. et al. Efficacy of vacuum erectile device in refractory erectile dysfunction: systematic review/meta-analysis. 2025.
[19] Senel S. et al. Stem cell therapy for erectile dysfunction: promise or reality? 2025.
[20] Ioannis M. et al. Update on penile prosthesis. 2025; also Baudry A. et al., 50 years of inflatable penile implants: Where do we stand now? 2024.
[21] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Erectile Dysfunction (ED): Definition, diagnosis, nutrition and facts.
[22] NIDDK. Treatment for Erectile Dysfunction.
[23] NHS. Erectile dysfunction (impotence).
[24] Mayo Clinic. Erectile dysfunction: symptoms and causes.
[25] Johns Hopkins Medicine. Erectile Dysfunction




















